D
Dezhi Mu
Researcher at Sichuan University
Publications - 300
Citations - 7665
Dezhi Mu is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Neuroprotection. The author has an hindex of 39, co-authored 269 publications receiving 6130 citations. Previous affiliations of Dezhi Mu include University of California, San Francisco & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1
Dezhi Mu,Stephanie Cambier,Stephanie Cambier,Lars Fjellbirkeland,Lars Fjellbirkeland,Jody L. Baron,John S. Munger,Hisaaki Kawakatsu,Dean Sheppard,Dean Sheppard,V. Courtney Broaddus,V. Courtney Broaddus,Stephen L. Nishimura,Stephen L. Nishimura +13 more
TL;DR: It is shown that SLC binds to αvβ8, an integrin expressed by normal epithelial and neuronal cells in vivo, which results in the membrane type 1 (MT1)-MMP–dependent release of active TGF-β, which leads to autocrine and paracrine effects on cell growth and matrix production.
Journal ArticleDOI
Chinese expert consensus on the perinatal and neonatal management for the prevention and control of the 2019 novel coronavirus infection (First edition)
Laishuan Wang,Yuan Shi,Tiantian Xiao,Tiantian Xiao,Jianhua Fu,Xing Feng,Dezhi Mu,Qi Feng,Mingyan Hei,Xiao-jing Hu,Zhankui Li,Guoping Lu,Zezhong Tang,Ya-Juan Wang,Chuan-qing Wang,Shiwen Xia,Jianqing Xu,Yujia Yang,Jie Yang,Mei Zeng,Jun Zheng,Wei Zhou,Xiaoyu Zhou,Xiao-Guang Zhou,Lizhong Du,Shoo K. Lee,Shoo K. Lee,Wenhao Zhou +27 more
TL;DR: To prevent and control infection, there should be practical measures to ensure the optimal management of children potentially to be infected in neonatal intensive care unit (NICU), the Chinese Neonatal 2019-nCoV expert working Group has put forward measures.
Journal ArticleDOI
Apnea of prematurity: from cause to treatment
TL;DR: The physiology and pathophysiology behind AOP are discussed, including the laryngeal chemoreflex and sensitivity to inhibitory neurotransmitters, as are the mechanisms by which different therapies may work and the potential long-term neurodevelopmental consequences of AOP and its treatment.
Journal ArticleDOI
Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.
Fernando F. Gonzalez,Patrick S. McQuillen,Dezhi Mu,Yunsil Chang,Michael F. Wendland,Zinaida S. Vexler,Donna M. Ferriero +6 more
TL;DR: The results suggest that EPO may neuroprotect and direct cell fate toward neurogenesis and away from gliogenesis in neonatal stroke.
Journal ArticleDOI
Erythropoietin improves functional and histological outcome in neonatal stroke.
Yun Sil Chang,Yun Sil Chang,Dezhi Mu,Michael F. Wendland,R Ann Sheldon,Zinaida S. Vexler,Patrick S. McQuillen,Donna M. Ferriero +7 more
TL;DR: EPO treatment markedly preserved hemispheric volume and decreased the expansion of SVZ unilaterally and significantly improved the asymmetry of forelimb use following neonatal stroke, suggesting EPO may be a candidate in the treatment of Neonatal stroke.